FTT 0.00% 0.5¢ factor therapeutics limited

Promoting and running a trial costs lots of cash - but that'll...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    Promoting and running a trial costs lots of cash - but that'll drop off.

    $6.4m minus $3m, so $3.4m at the end of this quarter.

    But if results are good then a deal or takeover is likely to occur.

    The company seemed pretty confident. They even tried to get the trial done without the last cap raising. It seemed like as long as they could scrape to the finish line all was ok.

    They will be well known to the likes of Smith & Nephew for years. I can imagine that a partner or suitor is already there, just waiting to see those trial figures.
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.